SCHEMBL567215

SCHEMBL567215

O=Cc1cnccc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30431215 1.00
Hydrochloric Acid SCHEMBL17558821 0.98 TRIM24 (0.41)
Bromide SCHEMBL18228259 0.98 TRIM24 (0.41)
SCHEMBL526587 0.84
SCHEMBL30570000 0.84
SCHEMBL29955436 0.78 KMT2A (0.46)
SCHEMBL2600757 0.78 KMT2A (0.46)
SCHEMBL25401071 0.77
SCHEMBL25225132 0.77
SCHEMBL31319806 0.75 MAOA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161642-B1 N-PHENYLAMINOCARBONYL PYRIDINO- , PYRIMIDINO AND BENZO-TROPANES AS MODULATORS OF GPR65 PATHIOS THERAPEUTICS LTD (GB) 2026-05-27 EP disclosed
CN-118772048-A HDAC inhibitor and application thereof 微境生物医药科技(上海)有限公司 2024-10-15 CN disclosed
US-12063850-B2 Organometallic compound, organic light-emitting device including the same and electronic apparatus including the organic light-emitting device SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-08-13 US disclosed
WO-2024138486-A1 TETRACYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-07-04 WO disclosed
US-20240186520-A1 RESIN COMPOSITION FOR SECONDARY BATTERY ELECTRODE SEKISUI CHEMICAL CO., LTD. (JP) 2024-06-06 US disclosed
US-20240166669-A1 QUINAZOLINE AMINE DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. 2024-05-23 US disclosed
WO-2024091409-A1 TRICYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-05-02 WO disclosed
EP-3782996-B1 NRF2 REGULATORS GLAXOSMITHKLINE IP DEV LTD (GB) 2024-04-10 EP disclosed
WO-2024051721-A1 TETRACYCLIC DERIVATIVES AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-03-14 WO disclosed
US-11905288-B1 Pyrido[3″,4″:4′, 5′]pyrrolo[3′,2′:4,5]imidazole[1,2-c]pyrimidine compounds as CK2 inhibitors King Faisal University (SA) 2024-02-20 US disclosed
US-5922723-A ADMINISTERING TO THE PATIENT SUFFERING WITH CENTRAL NERVOUS SYSTEM DISORDER A 2-AZABICYCLO(2,2,1)HEPT-5-ENE DERIVATIVE BENCHERIF MEROUANE (US) 1999-07-13 US disclosed
EP-0758321-B1 3-SUBSTITUTED PYRIDINE COMPOUNDS AND DERIVATIVES THEREOF AS HERBICIDES ZENECA LTD (GB) 1999-04-21 EP disclosed
US-5763357-A HERBICIDES ZENECA LIMITED (GB) 1998-06-09 US disclosed
WO-1997036902-A1 TRANS-2,6-, 3,6- AND 4,6-DIAZA-5,6,6a,7,8,12b-HEXAHYDROBENZO[C]PHENANTHRENE COMPOUNDS AS DOPAMINE AGONISTS ABBOTT LABORATORIES (US) 1997-10-09 WO disclosed
US-5668141-A TREATMENT OF PSYCHOLOGICAL, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS ABBOTT LABORATORIES (US) 1997-09-16 US disclosed
EP-0758321-A1 3-SUBSTITUTED PYRIDINE COMPOUNDS AND DERIVATIVES THEREOF AS HERBICIDES ZENECA LIMITED (GB) 1997-02-19 EP disclosed
US-5595958-A HERBICIDES ZENECA LIMITED (GB) 1997-01-21 US disclosed
US-5583140-A ADMINISTERING 2-AZABICYCLO(2.2.2)OCT-5-ENE DERIVATIVES TO TREAT NEURODEGENERATIVE DISORDERS SUCH AS SENILE DEMENTIA OF ALZHEIMER'S TYPE TARGACEPT, INC. A CORP. OF DE, 1996-12-10 US disclosed
WO-1996036637-A1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS R.J. REYNOLDS TOBACCO COMPANY (US) 1996-11-21 WO disclosed
WO-1995029893-A1 3-SUBSTITUTED PYRIDINE COMPOUNDS AND DERIVATIVES THEREOF AS HERBICIDES ZENECA LIMITED (GB) 1995-11-09 WO disclosed